Fact.MR’s recent glaucoma therapeutics industry report concludes that the market will reach US$ 6.6 Bn by the end of 2021. Long-term forecast suggests a largely steady outlook, [read full press release…]
Seoul, South Korea, 2022-Jun-01 — /EPR Network/ — Glaucoma Therapeutics Market Report By Drug Class (Prostaglandins, Beta Blockers, Alpha Agonists, Carbonic, Anhydrase Inhibitors, Combination Medications, [read full press release…]
Glaucoma Therapeutics Market Report By Drug Class (Prostaglandins, Beta Blockers, Alpha Agonists, Carbonic, Anhydrase Inhibitors, Combination Medications, Cholinergic Medications), By End User (Hospitals, Ophthalmic Clinics, [read full press release…]
